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analyses to identify factors associated with 25(OH)D as possible confounders of any association 206 with AMD and carried out a similar analysis for vitamin D status. We used univariable and 207 confounder-adjusted logistic regression to investigate associations between 25(OH)D or vitamin 208 D status and early grades of AMD and nvAMD. We also present results for all late AMD 209 (nvAMD and GA combined) as numbers with GA were too small (n=46) to permit meaningful 210 separate analyses. Analyses took account of the study design by including study centre in 211 models and by use of robust errors in Stata. 27 We report associations of individual SNPs with 212 early, late and nvAMD at a nominal significance of p<0.05. Since our a priori hypothesis of an 213 association between SNPs in vitamin D-related genes and AMD was based on previously 214 demonstrated associations of vitamin D genes with 25(OH)D, 4 5 we applied a Bonferroni 215 correction based on the number of SNPs within each gene in the AMD analyses in preference to 216 a GWAS type correction for all 92 snps. We also investigated whether any association of comparisons p <0.0001). Vitamin D deficiency was found in 21% (n=944) and 32.8% (1475) 230 were classified as insufficient. Only 13.4% (604) had concentrations of 75 nmol/L or greater. A 231 large number of variables were independently associated with 25(OH)D. In multivariable 232 analyses adjusted for center and season, levels were lower with increasing age, in women, in 233 current smokers, participants with diabetes, and higher in those taking fish oil supplements, and 234 drinking alcohol at least weekly. 25(OH)D was associated with higher UVB exposure, dietary 235 vitamin D intake, serum cholesterol, and plasma concentrations of ascorbate, lutein (or 236 zeaxanthin), and retinol (all associations, p<0.05 or less). There was no association with 237 education. Lutein and zeaxanthin were highly correlated (r=0.85) and therefore associations with 238 25(OH)D were almost identical. The characteristics of people categorized by 25(OH)D status 239 are shown in Table 1 (univariable analyses) . Proportionately fewer people classified as 240 insufficient or deficient took fish oil supplements or consumed oily fish at least weekly, were 241 less likely to be in the highest quartile of dietary vitamin D intake, or dietary docosahexaenoic 242 acid intake, and were more likely to be older or obese compared to those with sufficient levels.
243

Associations with AMD 244
Covariate-adjusted models showed no association of 25(OH)D with any grade of early AMD or 245 late or nvAMD (Table 2) . 25(OH)D status was not associated with any grade of early or late 246 AMD ( Table 2) . For nvAMD, deficient status was associated with a covariate adjusted OR of 247 1.27, 95% confidence interval (1.11-1.45) p<0.0001. Although numbers with GA were small 248 there was no indication of increased odds for deficiency status (OR=0.82, 0.36-1.89). We found 249 no significant interactions with rs1061170 or rs10490924 with 25(OH)D status and nvAMD 250 (p=0.32 and 0.30 respectively) or early AMD (p=0.28 and 0.11).
Genetic associations 252
Genotype data were available for 93 SNPs from 1284 participants selected for genetic analysis. 253 One SNP in GC was excluded for failing to meet the quality filters of call rates below 95% or 254 deviation from HWE (P<0.001). The average call rate for the remaining SNPs was 99.3%. No for age although AMD cases were older than non-AMD. 19 Using records of a mobile geriatric 284 clinic of 26 late AMD cases and 34 with no AMD signs, 25(OH)D deficiency was associated 285 with a 3 fold OR, 95% CI, 1-9, results were adjusted only for age, sex and season of blood In our study, 25(OH)D was measured in stored blood samples collected at the same time as the 298 ascertainment of AMD. We cannot therefore exclude the possibility of reverse causation i.e. that 299 nvAMD, directly or indirectly, influenced the 25(OH)D levels, for example as a result of 300 complement-related or other inflammatory effects. 11 We had no information on co-morbidities Genetic variants in vitamin D pathway members are not subject to concerns of temporality and 313 confounding and therefore provide stronger evidence on the possible association of vitamin D 314 with AMD. SNPs in the CYP24A1 and VDR gene were identified in the discovery phase of a 315 family nvAMD study but in the replication component, only variants in CYP24A1 were found to 316 be associated. 9 In the CAREDS study, SNPs in CYP2R1 and VDR but not CYP24A1 were 317 associated with early AMD. 15 In our study, we found no significant associations between variants in CYP2R1 and early AMD but a nominal association with two VDR SNPs. A VDR 319 SNP (rs11574077) was significantly associated with nvAMD in our study but this SNP was not 320 associated with nvAMD in a family study. 9 We found the strongest evidence of nominal 321 association for SNPs located within the RXRA gene region (rs12339187, rs3118536, rs11185644, 322 rs10881582), although these did not withstand correction for multiple testing. A limitation of 323 our study was the small number of cases of early and nvAMD for investigation of genetic 324 associations.
325
Genetic determinants of vitamin D bioactivity have been identified previously in the genes 326 encoding VDR and the retinoic acid-X-receptor (RXRA), which forms a complex with 1,25 OH 2 327 D bound to VDR and is recognized by vitamin D response elements on target genes. 35 We 328 directly genotyped rs1570669 and rs2274130 in CYP24A1, together with rs927651 as a proxy for 329 rs1570670, rs2296239 and rs4809957, all SNPs in high linkage disequilibrium. We found no 330 evidence to support their previously reported association with AMD. 13 In addition, previous 331 reports of VDR SNPs associated with AMD offer little support for our study findings and vice 332 versa, 19 although lack of support may result from discrepancies in recruitment and composition, 333 study size and characterization of the AMD cases within each study. In contrast to a previous 334 finding we found no evidence that major AMD genetic risk variants (rs1061170 and rs10490924) 335 modified the association between 25(OH)D deficiency and early AMD and nvAMD. 19 We did 336 not find a relationship with RXRA SNPs and 25(OH)D; however, a previous association with one 337 RXRA SNP (rs9409929) has been reported only with the metabolite 1,25 OH 2 D but not the 338 circulating serum level. 36 It is possible that the nominal association we report between RXRA 339 variants and nvAMD may not relate to vitamin D. RXRA receptors are involved in a large 340 number of pathways other than those related to vitamin D including, of relevance to AMD, glucose and lipid metabolism 37 and the omega 3 fatty acid, docosahexaenoic acid. 38 We conclude therefore that the hypothesis of a causal association of vitamin D with AMD is not Abbreviations: CHR, chromosome; SNP, single nucleotide polymorphism; BP, base pair; P, P value; OR, odds ratio; CI, confidence intervals.
